InícioPodcastsThe Long Run with Luke TimmermanEp209: Mathai Mammen on Developing Drugs Against Undruggable TargetsThe Long Run with Luke TimmermanEp209: Mathai Mammen on Developing Drugs Against Undruggable Targets9 de setembro de 2026 · 1 h 36 minTocar episódioCompartilhar a partir daquiNotas do episódioMathai Mammen, CEO of Cambridge, Mass.-based Parabilis Medicine, on developing alpha helical peptide molecules against hard targets of disease.Todos os episódios de The Long Run with Luke Timmerman